{"id":409854,"date":"2026-01-16T01:07:30","date_gmt":"2026-01-16T01:07:30","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/409854\/"},"modified":"2026-01-16T01:07:30","modified_gmt":"2026-01-16T01:07:30","slug":"2200000-of-eli-lilly-and-company-lobbying-was-just-disclosed","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/409854\/","title":{"rendered":"$2,200,000 of ELI LILLY AND COMPANY lobbying was just disclosed"},"content":{"rendered":"

$2,200,000 of ELI LILLY AND COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.<\/p>\n

This included lobbying on issues like:<\/p>\n

“Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil; US Tariffs
\n Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the “Inflation Reduction Act” (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)
\n Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage, value and access; Implementation of the “Inflation Reduction Act” (HR.5376); CMS National Coverage Determination on Alzheimer’s disease; One Big Beautiful Bill Act (HR.1)
\n Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality
\n Pharmaceutical intellectual property issues
\n Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping; One Big Beautiful Bill Act (HR.1)
\n Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act”<\/p>\n

You can find more data on corporate lobbying on Quiver Quantitative<\/a>.<\/p>\n

LLY Congressional Stock Trading<\/p>\n

Members of Congress have traded $LLY stock 11 times in the past 6 months. Of those trades, 6 have been purchases and 5 have been sales.<\/p>\n

Here\u2019s a breakdown of recent trading of $LLY stock<\/a> by members of Congress over the last 6 months:<\/p>\n

REPRESENTATIVE DAVID TAYLOR<\/a> has traded it 3 times. They made 2 purchases worth up to $65,000 on 08\/14 and 1 sale worth up to $15,000 on 12\/10.SENATOR JOHN BOOZMAN<\/a> has traded it 3 times. They made 2 purchases worth up to $30,000 on 08\/22, 08\/11 and 1 sale worth up to $15,000 on 11\/21.REPRESENTATIVE GILBERT RAY CISNEROS, JR.<\/a> purchased up to $15,000 on 11\/18.REPRESENTATIVE JULIE JOHNSON<\/a> has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11\/13, 08\/14.SENATOR SHELLEY MOORE CAPITO<\/a> purchased up to $15,000 on 10\/24.REPRESENTATIVE VAL T. HOYLE<\/a> sold up to $15,000 on 09\/23.<\/p>\n

To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard.<\/a><\/p>\n

LLY Insider Trading Activity\"LLY<\/a><\/p>\n

LLY insiders have traded $LLY stock on the open market 335 times in the past 6 months. Of those trades, 9 have been purchases and 326 have been sales.<\/p>\n

Here\u2019s a breakdown of recent trading of $LLY stock<\/a> by insiders over the last 6 months:<\/p>\n

ENDOWMENT INC LILLY has made 0 purchases and 323 sales selling 3,691,128 shares for an estimated $3,403,079,143.DONALD A ZAKROWSKI<\/a> (SVP, Finance, & CAO) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $1,745,430.DAVID A RICKS<\/a> (President, Chair, and CEO) purchased 1,632 shares for an estimated $1,052,263J ERIK FYRWALD<\/a> has made 2 purchases buying 1,565 shares for an estimated $1,005,242 and 0 sales.ILYA YUFFA<\/a> (EVP&Pres, LLY USA&Global Capab) sold 1,250 shares for an estimated $783,762NAARDEN JACOB VAN<\/a> (EVP & Pres., Lilly Oncology) purchased 1,000 shares for an estimated $647,360DANIEL SKOVRONSKY<\/a> (EVP, CSO & Pres. LRL & LLY Imm) purchased 1,000 shares for an estimated $634,405RALPH ALVAREZ<\/a> purchased 758 shares for an estimated $500,472LUCAS MONTARCE<\/a> (EVP & CFO) purchased 715 shares for an estimated $494,626JAMERE JACKSON<\/a> purchased 200 shares for an estimated $127,912GABRIELLE SULZBERGER purchased 117 shares for an estimated $75,018<\/p>\n

To track insider transactions, check out Quiver Quantitative’s insider trading dashboard.<\/a><\/p>\n

LLY Hedge Fund Activity<\/p>\n

We have seen 1,952 institutional investors add shares of LLY stock to their portfolio, and 1,642 decrease their positions in their most recent quarter.<\/p>\n

Here are some of the largest recent moves:<\/p>\n

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC<\/a> added 4,994,433 shares (+63.4%) to their portfolio in Q3 2025, for an estimated $3,810,752,379CAPITAL RESEARCH GLOBAL INVESTORS<\/a> added 4,332,008 shares (+20.9%) to their portfolio in Q3 2025, for an estimated $3,305,322,104PRICE T ROWE ASSOCIATES INC \/MD\/<\/a> removed 3,366,669 shares (-20.0%) from their portfolio in Q3 2025, for an estimated $2,568,768,447CAPITAL WORLD INVESTORS<\/a> removed 2,664,593 shares (-15.1%) from their portfolio in Q3 2025, for an estimated $2,033,084,459JPMORGAN CHASE & CO<\/a> removed 2,242,818 shares (-17.9%) from their portfolio in Q3 2025, for an estimated $1,711,270,134GEODE CAPITAL MANAGEMENT, LLC<\/a> added 1,689,260 shares (+9.3%) to their portfolio in Q3 2025, for an estimated $1,288,905,380TIGER GLOBAL MANAGEMENT LLC<\/a> removed 1,511,160 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,153,015,080<\/p>\n

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.<\/a><\/p>\n

LLY Analyst Ratings<\/p>\n

Wall Street analysts have issued reports on $LLY in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.<\/p>\n

Here are some recent analyst ratings:<\/p>\n

B of A Securities issued a “Buy” rating on 12\/15\/2025Wells Fargo issued a “Overweight” rating on 12\/10\/2025BMO Capital issued a “Outperform” rating on 12\/04\/2025Morgan Stanley issued a “Overweight” rating on 11\/24\/2025Bernstein issued a “Outperform” rating on 11\/24\/2025Truist Securities issued a “Buy” rating on 11\/19\/2025JP Morgan issued a “Overweight” rating on 11\/18\/2025<\/p>\n

To track analyst ratings and price targets for LLY, check out Quiver Quantitative’s $LLY forecast page.<\/a><\/p>\n

LLY Price Targets<\/p>\n

Multiple analysts have issued price targets for $LLY recently. We have seen 17 analysts offer price targets for $LLY in the last 6 months, with a median target of $1150.0.<\/p>\n

Here are some recent targets:<\/p>\n

Michael Yee from UBS set a target price of $1250.0 on 01\/07\/2026 Tim Anderson from B of A Securities set a target price of $1268.0 on 12\/15\/2025 Mohit Bansal from Wells Fargo set a target price of $1200.0 on 12\/10\/2025 Evan Seigerman from BMO Capital set a target price of $1200.0 on 12\/04\/2025 Terence Flynn from Morgan Stanley set a target price of $1290.0 on 11\/24\/2025 Courtney Breen from Bernstein set a target price of $1300.0 on 11\/24\/2025 Robyn Karnauskas from Truist Securities set a target price of $1182.0 on 11\/19\/2025 <\/p>\n

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.<\/p>\n","protected":false},"excerpt":{"rendered":"$2,200,000 of ELI LILLY AND COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying…\n","protected":false},"author":2,"featured_media":409855,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[97,252,253],"class_list":{"0":"post-409854","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-care","8":"tag-health","9":"tag-health-care","10":"tag-healthcare"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/409854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=409854"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/409854\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/409855"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=409854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=409854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=409854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}